Effects of morning or bedtime dosing of the valsartan/amlodipine on nocturnal blood pressure and target organ protection in patients with hypertensio
- Conditions
- Hypertension
- Registration Number
- JPRN-UMIN000013519
- Lead Sponsor
- Division of Cardiovascular Medicine Jichi Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 26
Not provided
1) History of hypersensitivity to test drug or dihydropyridine compounds. 2) Patients being treated concomitantly with hypertensive drugs other than ARB or CCB 3) Secondary hypertension or malignant hypertension. 4) Severe heart failure (New York Heart Association (NYHA) functional class III or more). 5) Severe kidney disease with serum creatinine level 3.0mg/dL or higher, or on dialysis 6) Severe liver and biliary system disorders. 7) History of cardiovascular (myocardial infarction) or cerebrovascular (cerebral infarction) event 8) Patients with endocrine disease. 9) Patients with malignant neoplasms 10) Pregnant or women of child bearing potential 11) Patients who is not given informed consent by themselves 12) Patients decided inappropriate subjects for this study by physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method